Protective effects of pergolide in a 6-hydroxydopamine model of Parkinson's disease

被引：0
|
作者：
Ciobica, A.
Hritcu, L.
Artenie, V.
Padurariu, M.
机构：
[1] Alexandru Ioan Cuza Univ, Iasi, Romania
[2] Gr T Popa Univ, Socola Hosp, Iasi, Romania
来源：
JOURNAL OF NEUROLOGY | 2010年 / 257卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P194
引用
收藏
页码：S62 / S62
页数：1
相关论文
共 50 条
  • [1] The 6-hydroxydopamine model of Parkinson's disease
    Simola, Nicola
    Morelli, Micaela
    Carta, Anna R.
    NEUROTOXICITY RESEARCH, 2007, 11 (3-4) : 151 - 167
  • [2] Pergolide attenuates memory impairment and oxidative stress in a 6-hydroxydopamine model of Parkinson's disease
    Ciobica, A.
    Hritcu, L.
    Artenie, V.
    Bild, W.
    Padurariu, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S34 - S35
  • [3] The 6-Hydroxydopamine model of parkinson’s disease
    Nicola Simola
    Micaela Morelli
    Anna R. Carta
    Neurotoxicity Research, 2007, 11 : 151 - 167
  • [4] Pergolide attenuates memory impairment and oxidative stress induced by a 6-hydroxydopamine model of Parkinson's disease
    Ciobica, A.
    Hritcu, L.
    Padurariu, M.
    Bild, V
    Stoica, B.
    BRAIN PATHOLOGY, 2010, 20 : 29 - 30
  • [5] Neuroprotective effects of nicotine in a 6-hydroxydopamine model of Parkinson's disease
    Minamino, Hideaki
    Yanagida, Takashi
    Kitamura, Yoshihisa
    Taniguchi, Takashi
    Shimohama, Shun
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2008, 106 : 227P - 227P
  • [6] The 6-hydroxydopamine Rat Model of Parkinson's Disease
    Guimaraes, Rayanne Poletti
    Ribeiro, Danilo Leandro
    dos Santos, Keila Bariotto
    Godoy, Livea Dornela
    Correa, Mirella Rosine
    Padovan-Neto, Fernando Eduardo
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2021, (176):
  • [7] Neuroprotection by safinamide in the 6-hydroxydopamine model of Parkinson's disease
    Sadeghian, M.
    Mullali, G.
    Pocock, J. M.
    Piers, T.
    Roach, A.
    Smith, K. J.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2016, 42 (05) : 423 - 435
  • [8] Molecular Profiling of a 6-Hydroxydopamine Model of Parkinson’s Disease
    Sang J. Na
    Anthony G. DiLella
    Edward V. Lis
    Keith Jones
    David M. Levine
    David J. Stone
    J. F. Hess
    Neurochemical Research, 2010, 35 : 761 - 772
  • [9] Neuroprotection of edaravone in a 6-hydroxydopamine model of Parkinson's disease
    Li, G.
    Tian, J.
    MOVEMENT DISORDERS, 2006, 21 : S344 - S345
  • [10] Molecular Profiling of a 6-Hydroxydopamine Model of Parkinson's Disease
    Na, Sang J.
    DiLella, Anthony G.
    Lis, Edward V.
    Jones, Keith
    Levine, David M.
    Stone, David J.
    Hess, J. F.
    NEUROCHEMICAL RESEARCH, 2010, 35 (05) : 761 - 772
12345